Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank79
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-5.05%
↑ 85% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-33.93%
Historical baseline
PeriodValue
2025-5.05%
202416.18%
2023-12.16%
2022-15.67%
2021-31.85%
2020-31.40%
2019-59.86%
2018-34.23%
2017-74.05%
2016-91.23%